Doug Whitney, 76, carries a rare PSEN2 genetic mutation that causes early-onset Alzheimer's but shows no cognitive decline ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

New research from the University of Miami’s Miller School of Medicine has found striking similarities between the brains of ...

One MU Health Care neurologist says research on Alzheimer's disease treatments and prevention has rapidly accelerated in the ...

Doug Whitney from Seattle appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease ...

A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

Researchers say the experimental tool has huge implications for public health, especially in conjunction with Alzheimer’s drugs that are most effective in the disease’s early stages ...

It affects approximately 4 million people in the United States and is the fourth leading cause of death among adults. The number of people with Alzheimer's disease is expected to grow significantly ...

The new tool is a blood test. The FDA just gave it the green light to help doctors rule out Alzheimer's Disease. Statistics ...

Recent Food and Drug Administration approval of the first two blood tests used in detecting Alzheimer’s disease brings hope ...

Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and the ability to perform ...